+12.2%
IOT vs GSK
+31.2%
-19.1%
-46.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +3.7% | -1.9% | +5.7% | +3.3% |
| 7D | -2.3% | -1.8% | -0.5% | -2.7% |
| 30D | +3.8% | -2.2% | +6.0% | +3.4% |
| 3M | +14.2% | -1.8% | +16.0% | +14.0% |
| 6M | +40.1% | -10.6% | +50.7% | +37.8% |
| YTD | +13.4% | +4.4% | +9.0% | +10.3% |
| 1Y | +12.2% | +30.4% | -18.2% | +7.5% |
| All | +12.2% | +31.2% | -19.1% | +7.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling